The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use.
about
Management of the patient with eosinophilic asthma: a new era beginsVinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanismVinpocetine as a potent antiinflammatory agentDifferent effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injuryAntinoceptive and Anti-inflammatory Activities of the Ethanolic Extract, Fractions and Flavones Isolated from Mimosa tenuiflora (Willd.) Poir (Leguminosae)Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord.Immune mediated diseases and immune modulation in the neurocritical care unitThe relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-ChronicTemperature-controlled laminar airflow in severe asthma for exacerbation reduction (The LASER Trial): study protocol for a randomised controlled trial.Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation.Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects.Oral corticosteroid prescribing habits of Canadian Otolaryngologist-Head and Neck Surgeons.PURLs: corticosteroids for a sore throat?Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis.Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting.Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment.Cost effectiveness of treatments for inflammatory bowel disease.Corticosteroid-use in primary and secondary brain tumour patients: a review.Glucocorticoids in myasthenia gravis - if, when, how, and how much?Treatment of severe asthma: entering the era of targeted therapy.Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects.Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO).Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children.The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis.Quality of life and stressors in patients with chronic kidney disease depending on treatment.Treatment Patterns, Healthcare Resource Utilization, and Spending Among Medicaid-Enrolled Children with Chronic Idiopathic/Spontaneous Urticaria in the United States.Potent inhibitory effect of silibinin from milk thistle on skin inflammation stimuli by 12-O-tetradecanoylphorbol-13-acetate.Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus.Morbidity associated with oral corticosteroids in patients with severe asthma.The role of immediate postoperative systemic corticosteroids when utilizing a steroid-eluting spacer following sinus surgery.Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational studyA Charter to Improve Patient Care in Severe AsthmaHealth care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR)
P2860
Q28078191-3F477437-C484-46F3-A96B-13EB2E5C3BC1Q28281609-22138A9C-6F8A-4FAA-BE72-3CF78C7BB252Q28283160-9574043F-B869-4246-919B-CAB9B3880A45Q28482560-427D9A6D-3620-41A3-BCF4-5BDF0D0664A9Q28550593-6401EE9E-9528-4204-B388-90E21BDC66E3Q35590068-CAEF917A-291E-4ED4-8C09-B106036DB0C1Q35729575-BD450F98-78DF-4461-9718-AC5A80A58878Q35815301-D164585D-3647-4A6E-8429-A997836E6AECQ35888513-E54696E1-BB3D-429B-BC31-7EEE828F3922Q35906666-2B745393-342C-4BFB-85D8-46F2E93EA74AQ36016473-7AA252CF-3FDA-4D7A-9471-00300383C67FQ36242209-4CF0B059-7030-4431-AB06-222460B71DA1Q36634125-2C1C7B11-7B90-4E9A-8E58-E077238B0CE7Q36983176-5BC708AB-FEE4-4981-8EB7-EA1575612CD0Q37177646-59235983-6883-426C-9CED-923DF55240E6Q37342575-3EF3A9AF-8EC1-49A7-A959-D0B2FAD8628FQ37428213-F2B165D6-575E-4F4A-A9BA-2210F5DE2A3EQ37673352-4442F101-0103-4A75-8A81-FD86D8759520Q37832729-E63C55F4-16D7-4770-9817-F7A8E6450E4AQ37942476-B435F989-22C6-4D41-92F9-7A5BF5D9DFF3Q38234725-5BF4CF59-2981-49E7-95E3-DF996BAD80C9Q38578918-3721A432-AB5E-41A2-AA7D-5405282E1543Q38848760-310B1401-ED36-4E9E-8ECD-176FDACB0761Q39918274-841C3EE0-A4CB-4A8B-8AC1-44CA8600EF89Q44615394-F3E01AA0-5E43-4ABF-8A27-C8C219FB1BB9Q47282148-C38C39D1-35C7-4DB3-9F6E-66AB20C01C1BQ47318170-40C586E7-D251-4058-9AE8-E0D38B78E3CBQ47769040-8130C01D-D6D6-4EB5-9003-3AC8DAAAF31DQ47977116-B42BECAF-8973-4B92-8F76-2436763F1C1FQ50079211-B8F6103B-C267-40EC-8F28-EAA37CBA488CQ50246492-B08EB04D-5260-4295-8FEF-5A091EC0FB6EQ50910043-F201494C-A832-4684-A0EA-43A9373DDA52Q51545298-25FFEEC2-B9AF-48D4-A674-B716E59EDD06Q53628902-0D2D04AD-80E0-46A0-ACE7-3D076F448F48Q54227322-A785B077-6FF7-4B12-AC9C-093130B7ACDEQ58694343-BC49ED5A-18BB-4614-B3B1-CE61433ED2F2Q58764055-8D908194-E216-4893-A050-C6AB37284E35Q58769009-A6724039-DE4C-426E-9105-EF46BC1893E5
P2860
The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The cumulative burden of oral ...... c implications of steroid use.
@en
The cumulative burden of oral ...... c implications of steroid use.
@nl
type
label
The cumulative burden of oral ...... c implications of steroid use.
@en
The cumulative burden of oral ...... c implications of steroid use.
@nl
prefLabel
The cumulative burden of oral ...... c implications of steroid use.
@en
The cumulative burden of oral ...... c implications of steroid use.
@nl
P2093
P1433
P1476
The cumulative burden of oral ...... c implications of steroid use.
@en
P2093
Annamaria Cerulli
Carlos Fernandez Vidaurre
Ruth E Brown
Stephanie C Manson
P304
P356
10.1016/J.RMED.2009.01.003
P577
2009-04-15T00:00:00Z